Prevalence and clinical characteristics of ankylosing spondylitis in Iceland - A nationwide study

Clinical and Experimental Rheumatology

Volumn 28, Issue 3, 2010, Pages 333-340

  Geirsson, Arni Jon ^a   Eyjolfsdottir, Helga ^a   Bjornsdottir, Gyda ^c   Kristjansson, Kristleifur ^c   Gudbjornsson, Bjorn ^a,b  

^a LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^b UNIVERSITY OF ICELAND   (Iceland)

^c DECODE GENETICS   (Iceland)

Author keywords

Ankylosing spondylitis; Demographics; Nationwide; Prevalence

Indexed keywords

CELECOXIB; HLA B27 ANTIGEN; INFLIXIMAB; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; SALAZOSULFAPYRIDINE;

ADULT; ANKYLOSING SPONDYLITIS; ARTICLE; CLINICAL EVALUATION; FEMALE; HUMAN; ICELAND; IRITIS; MAJOR CLINICAL STUDY; MALE; PHYSIOTHERAPY; PREVALENCE; PRIORITY JOURNAL; PROSTATISM; QUESTIONNAIRE; RHEUMATOLOGY; ADOLESCENT; CAUCASIAN; GENETICS; HOSPITALIZATION; INCIDENCE; ONSET AGE; PATHOPHYSIOLOGY; STATISTICS;

ADOLESCENT; ADULT; AGE OF ONSET; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HLA-B27 ANTIGEN; HUMANS; ICELAND; INCIDENCE; MALE; PREVALENCE; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; SPONDYLITIS, ANKYLOSING; YOUNG ADULT;

EID: 77955435585     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. GRAN JT, HUSBY G: The epidemiology of ankylosing spondylitis. Semin Arthritis Rheum 1993; 22: 319-34.
2. KAIPIAINEN-SEPPANEN O, AHO K, HELIOVAARA M: Incidence and prevalence of ankylosing spondylitis in Finland. J Rheumatol 1997; 24: 496-9.
3. RUDWALEIT M, METTER A, LISTING J, SIEPER J, BRAUN J: Inflammatory back pain in ankylosing spondylitis: A reassessment of the clinical history for application as classification and diagnostic criteria. Arthritis Rheum 2006; 54: 569-78.
4. KHAN MA: Clinical features of ankylosing spondylitis. In: HOCHBERG M, SILMAN A, SMOLEN J, WEINBLATT M (Eds.) Rheumatology. London: Mosby: A Division of Harcourt Health Sciences Ltd. 2003:1161-81.
5. KHAN MA: Update on spondyloarthropathies. Ann Intern Med 2002; 136: 896-907.
6. MASON RM, MURRAY RS, OATES JK, YOUNG AC: Prostatitis and ankylosing spondylitis. BMJ 1958; 1: 748-51.
7. LANGE U, BERLINER M, WEIDNER W, SCHIEFER HG, SCHMIDT KL, FEDERLIN K: Ankylosing spondylitis and urogenital infection: Diagnosis of urologic infection and correlation with rheumatologic findings. Z Rheumatol 1996; 55: 249-55.
8. SMALE S, NATT RS, ORCHARD TR, RUSSELL AS, BJARNASON I: Inflammatory bowel disease and spondylarthropathy. Arthritis Rheum 2001; 44: 2728-36.
9. BERGFELDT L: HLA-B27-associated cardiac disease. Ann Intern Med 1997; 127: 621-9.
10. ROSENOW E, STRIMLAN CV, MUHM JR, FERGUSON RH: Pleuropulmonary manifestations of ankylosing spondylitis. Mayo Clin Proc 1977; 52: 641-9.
11. MOLL JM, WRIGHT V: New York clinical criteria for ankylosing spondylitis: A statistical evaluation. Ann Rheum Dis 1973; 32: 354-63.
12. VAN DER LINDEN S, VALKENBURG HA, CATS A: Evaluation of diagnostic criteria for ankylosing spondylitis: A proposal for modification of the New York criteria. Arthritis Rheum 1984; 27: 361-8.
13. BREWERTON DA, HART FD, NICHOLLS A, CAFFREY M, JAMES DC, STURROCK RD: Ankylosing spondylitis and HL-A 27. Lancet 1973; 1: 904-7.
14. SIEPER J, RUDWALEIT M, KHAN MA, BRAUN J: Concepts and epidemiology of spondyloarthritis. Best Pract Res Clin Rheumatol 2006; 20: 401-17.
15. FERNÁNDEZ-SUEIRO JL, ALONSO C, BLANCO FJ, RODRÍGUEZ- GÓMEZ M, GALDO F, GONZÁLEZ-GAY M: Prevalence of HLA-B27 and subtypes of HLA-B27 associated with ankylosing spondylitis in Galicia, Spain. Clin Exp Rheumatol 2004; 22: 465-8.
16. VAN DER LINDEN SM, VALKENBURG HA, DE JONGH BM, CATS A: The risk of developing ankylosing spondylitis in HLA-B27 positive individuals: A comparison of relatives of spondylitis patients with the general population. Arthritis Rheum 1984; 27: 241-9.
17. GRAN JT, HUSBY G, HORDVIK M: Prevalence of ankylosing spondylitis in males and females in a young middle-aged population of Tromso, northern Norway. Ann Rheum Dis 1985; 44: 359-67.
18. DE ANGELIS R, SALAFFI F, GRASSI W: Prevalence of spondylarthropathies in an Italian population sample: A regional community-based study. Scand J Rheumatol 2007; 36: 14-21.
19. ALAMAMNOS Y, PAPADOPOULOS NG, VOULGARI PV, KARAKATSANIS A, SIOZOS C, DROSOS AA: Epidemiology of ankylosing spondylitis in Northwest Greece, 1983-2002. Rheumatology (Oxford) 2004; 43: 615-8.
20. GOFTON JP, ROBINSON HS, TRUEMAN GE: Ankylosing spondylitis in a Canadian Indian population. Ann Rheum Dis 1966; 25: 525-7.
21. BAKLAND G, NOSSENT HC, GRAN JT: Incidence and prevalence of ankylosing spondylitis in Northern Norway. Arthritis Rheum 2005; 53: 850-5.
22. THJODLEIFSSON B, GEIRSSON AJ, BJORNSSON S, BJARNASON I: A common genetic background for inflammatory bowel disease and ankylosing spondylitis: A genealogic study in Iceland. Arthritis Rheum 2007; 56: 2633-9.
23. LOVE TJ, GUDBJORNSSON B, GUDJONSSON JE, VALDIMARSSON H: Psoriatic arthritis in Reykjavik, Iceland: Prevalence, demographics, and disease course. J Rheumatol 2007; 34: 2082-8.
24. MOLL JMH, WRIGHT V: An objective study of chest expansion. Ann Rheum Dis 1972; 31: 1-8.
25. Personal communication; Data on file, deCode Genetics Ltd, Iceland.
26. Statistics Iceland. Population by sex and age. 2009; Available at: ww.statice.is. Accessed December 10, 2008.
27. TRONTZAS P, ANDRIANAKOS A, MIYAKIS S et al.: Seronegative spondyloarthropathies in Greece: A population-based study of prevalence, clinical pattern, and management. The ESORDIG study. Clin Rheumatol 2005; 24: 583-9.
28. CARBONE LD, COOPER C, MICHET CJ, ATKINSON EJ, O'FALLON WM, MELTON LJ 3RD: Ankylosing spondylitis in Rochester, Minnesota, 1935-1989: Is the epidemiology changing? Arthritis Rheum 1992; 35: 1476-82.
29. ADOMAVICIUTE D, PILECKYTE M, BARANAUSKAITE A, MORVAN J, DADONIENE J, GUILLEMIN F: Prevalence survey of rheumatoid arthritis and spondyloarthropathy in Lithuania. Scand J Rheumatol 2008; 37: 113-9.
30. HART FD, ROBINSON KC: Ankylosing spondylitis in women. Ann Rheum Dis 1959; 18: 15-23.
31. ZINK A, BRAUN J, LISTING J, WOLLENHAUPT J: Disability and handicap in rheumatoid arthritis and ankylosing spondylitis: Results from the German rheumatological database. German Collaborative Arthritis Centers. J Rheumatol 2000; 27: 613-22.
32. DINCER U, CAKAR E, KIRALP MZ, DURSUN H: Diagnosis delay in patients with ankylosing spondylitis: Possible reasons and proposals for new diagnostic criteria. Clin Rheumatol 2008; 27: 457-62.
33. LEE W, REVEILLE JD, DAVIS JC JR, LEARCH TJ, WARD MM, WEISMAN MH: Are there gender differences in severity of ankylosing spondylitis? Results from the PSOAS cohort. Ann Rheum Dis 2007; 66: 633-8.
34. ZOCHLING J, BRAUN J: Mortality in ankylosing spondylitis. Clin Exp Rheumatol 2008; 26 (Suppl. 51): S80-4.
35. SMITH JA, MARKER-HERMANN E, COLBERT RA: Pathogenesis of ankylosing spondylitis: current concepts. Best Pract Res Clin Rheumatol 2006; 20: 571-91.
36. KIM TJ, NA KS, LEE HJ, LEE B, KIM TH: HLA-B27 homozygosity has no influence on clinical manifestations and functional disability in ankylosing spondylitis. Clin Exp Rheumatol 2009; 27: 574-9
37. PEDERSEN OB, SVENDSEN AJ, EJSTRUP L, SKYTTHE A, HARRIS JR, JUNKER P: Ankylosing spondylitis in Danish and Norwegian twins: Occurrence and the relative importance of genetic vs. environmental effectors in disease causation. Scand J Rheumatol 2008; 37: 120-6.